Recent scRNA-seq data demonstrated that overexpressed A20 could suppress inflammatory transcripts induced by IL-17A in NHEK cells (Harirchian et al., 2019), indicating that A20 provides a potential AD therapeutic modality against inflammation. This evidence concerns the gene TNFAIP3 and Alzheimer disease.